Vns and epilepsy

Brian N. Lundstrom; William O. Tatum

doi:10.1007/978-3-030-59078-9_46

Vns and epilepsy

Brian N. Lundstrom, William O. Tatum

Neurology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Vagus nerve stimulation (VNS) is a treatment option for adult and pediatric patients with drug-resistant focal or generalized epilepsy. Typically, seizure frequency will be reduced by at least half in at least one-third of patients. Seizure freedom is rarely achieved with VNS. Hoarseness is a typical and expected side effect of stimulation. Newer VNS devices provide stimulation in response to heart rate changes. VNS therapy is an attractive approach as an adjunctive treatment for patients with drug-resistant epilepsy and difficulty tolerating antiseizure medications (ASM).

Original language	English (US)
Title of host publication	Epilepsy Case Studies
Subtitle of host publication	Pearls for Patient Care: Second Edition
Publisher	Springer International Publishing
Pages	259-263
Number of pages	5
ISBN (Electronic)	9783030590789
ISBN (Print)	9783030590772
DOIs	https://doi.org/10.1007/978-3-030-59078-9_46
State	Published - Dec 19 2020

Keywords

Convulsions
Drug resistant
Genetic generalized epilepsy
Seizures
Sudden unexpected death in epilepsy
Vagus nerve stimulation

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-030-59078-9_46

Cite this

@inbook{e8a504d6998b45688939ca5a78153bf5,

title = "Vns and epilepsy",

abstract = "Vagus nerve stimulation (VNS) is a treatment option for adult and pediatric patients with drug-resistant focal or generalized epilepsy. Typically, seizure frequency will be reduced by at least half in at least one-third of patients. Seizure freedom is rarely achieved with VNS. Hoarseness is a typical and expected side effect of stimulation. Newer VNS devices provide stimulation in response to heart rate changes. VNS therapy is an attractive approach as an adjunctive treatment for patients with drug-resistant epilepsy and difficulty tolerating antiseizure medications (ASM).",

keywords = "Convulsions, Drug resistant, Genetic generalized epilepsy, Seizures, Sudden unexpected death in epilepsy, Vagus nerve stimulation",

author = "Lundstrom, {Brian N.} and Tatum, {William O.}",

year = "2020",

month = dec,

day = "19",

doi = "10.1007/978-3-030-59078-9_46",

language = "English (US)",

isbn = "9783030590772",

pages = "259--263",

booktitle = "Epilepsy Case Studies",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Vns and epilepsy

AU - Lundstrom, Brian N.

AU - Tatum, William O.

PY - 2020/12/19

Y1 - 2020/12/19

N2 - Vagus nerve stimulation (VNS) is a treatment option for adult and pediatric patients with drug-resistant focal or generalized epilepsy. Typically, seizure frequency will be reduced by at least half in at least one-third of patients. Seizure freedom is rarely achieved with VNS. Hoarseness is a typical and expected side effect of stimulation. Newer VNS devices provide stimulation in response to heart rate changes. VNS therapy is an attractive approach as an adjunctive treatment for patients with drug-resistant epilepsy and difficulty tolerating antiseizure medications (ASM).

AB - Vagus nerve stimulation (VNS) is a treatment option for adult and pediatric patients with drug-resistant focal or generalized epilepsy. Typically, seizure frequency will be reduced by at least half in at least one-third of patients. Seizure freedom is rarely achieved with VNS. Hoarseness is a typical and expected side effect of stimulation. Newer VNS devices provide stimulation in response to heart rate changes. VNS therapy is an attractive approach as an adjunctive treatment for patients with drug-resistant epilepsy and difficulty tolerating antiseizure medications (ASM).

KW - Convulsions

KW - Drug resistant

KW - Genetic generalized epilepsy

KW - Seizures

KW - Sudden unexpected death in epilepsy

KW - Vagus nerve stimulation

UR - http://www.scopus.com/inward/record.url?scp=85149789245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85149789245&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-59078-9_46

DO - 10.1007/978-3-030-59078-9_46

M3 - Chapter

AN - SCOPUS:85149789245

SN - 9783030590772

SP - 259

EP - 263

BT - Epilepsy Case Studies

PB - Springer International Publishing

ER -

Vns and epilepsy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this